Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 2 1Phase 1 1

Status

Completed 4Terminated 2

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4Sarcoma 3Plasma cell 3Gynecologic 3Head & Neck 2Dermatologic 2CNS 2Tumor-Agnostic 1Thoracic 1Other hematologic neoplasm 1Lymphoid 1Genitourinary 1

Conditions

Pancreatic Neoplasms 3Colorectal Neoplasms 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Nelfinavir × Gastrointestinal × Clear all
NCT02024009 2024-07-25

SCALOP-2

University of Oxford

Phase 1/2 Completed
159 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01068327 2023-10-10

Stereotactic Radiation, Nelfinavir Mesylate & Neoadjuvant Chemotherapy in Locally Advanced Pancreatic Cancer

University of Nebraska

Phase 1 Completed
46 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01959672 2023-10-10

Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer

University of Nebraska

Phase 2 Completed
11 enrolled 12 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00704600 2014-12-08

Nelfinavir

Maastricht Radiation Oncology

Phase 1/2 Completed
15 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡